Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/1992
10/29/1992WO1992018112A1 Method of preventing nmda receptor complex-mediated neuronal damage
10/29/1992WO1992018111A2 Pharmaceutical composition for the treatment of gastritis
10/29/1992WO1992018004A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs
10/29/1992WO1992015601A3 Heteroanthracycline antitumor analogs
10/29/1992WO1992014743A3 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/29/1992WO1992011370A3 Polypeptides derived from proteins of the hepatitis c virus
10/29/1992DE4113385A1 Hybridtransposon mit pt-operon, plasmide und bakterienstaemme dafuer Hybrid transposon with pt-operon, plasmids and bakterienstaemme for it
10/29/1992DE4111531A1 Plasmide zur fha-expression und wirte Plasmids for fha-expression and wirte
10/29/1992CA2108255A1 Anti-cancer compounds
10/29/1992CA2106673A1 Improved process for the preparation of [1s-(1r*,2s*,3r*)]-n-(4-morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
10/29/1992CA2102221A1 Abrogation of viral resistance to nucleoside analogues by double-stranded rnas
10/28/1992EP0511002A2 C-3 phosphine oxide substituted carbacephalosporins
10/28/1992EP0510996A1 Recombinant varicella-zoster virus vector
10/28/1992EP0510912A1 Antimicrobial peptide and antimicrobial agent
10/28/1992EP0510904A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510903A1 Novel lipophilic macrolide useful as an immunosuppressant
10/28/1992EP0510773A1 Canine coronavirus subunit vaccine
10/28/1992EP0510271A1 Novel R106 compounds
10/28/1992EP0510260A2 6'-C-alkyl-3-deazaneplanocin A derivative and its preparation process and use
10/28/1992EP0510080A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
10/28/1992EP0510079A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof
10/28/1992EP0509989A1 Method of preparing ribonuclease dimers.
10/28/1992EP0509984A1 Method of preparing lysozyme dimers
10/28/1992EP0441832A4 Composition and treatment with biologically active peptides and certain anions
10/28/1992CN1018845B 病毒疫苗 Virus vaccine
10/28/1992CN1018833B Alkyl-substituted benzoxazinorifamycin derivative, process for preparing same and antibacterial agent containing same
10/28/1992CN1018825B Process for preparation of poly-4-aminopyrrole-2-carboxamido derivatives
10/27/1992WO1992019970A1 Methods to detect and treat diseases caused by bacterial allergens
10/27/1992US5158946 Antibiotics, bactericides
10/27/1992US5158942 Process of using phospholipid derivatives to inhibit multiplication of the human immunodeficiency virus
10/27/1992US5158778 Stable antimicrobial dialdehyde composition and methods of use
10/27/1992CA2109088A1 Methods to detect and treat diseases caused by bacterial allergens
10/27/1992CA1309346C Pharmaceutical administration systems containing chemotactic peptides
10/26/1992WO1992019732A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992CA2102229A1 Closed sense and antisense oligonucleotides and uses thereof
10/26/1992CA2066492A1 C-3 phosphine oxide substituted carbacephalosporins
10/24/1992CA2066499A1 Lipophilic macrolide useful as an immunosuppressant
10/24/1992CA2066494A1 Lipophilic macrolide useful as an immunosuppressant
10/22/1992DE4211812A1 New water-soluble 2-(2,6-di:oxo-3-piperidinyl)-1H-iso-indole-1-di:one deriv. - may be administered parenterally and have comparable activity to thalidomide itself
10/21/1992EP0509906A1 Complexes of Polyadenylic acid with polyuridylic acid for the treatment of AIDS
10/21/1992EP0509780A1 2-phenanthridonyl carbapenems
10/21/1992EP0509756A1 2-Phenanthridonyl carbapenems having cationizeable substituents
10/21/1992EP0509753A1 Semi-synthetic immunosuppressive macrolides
10/21/1992EP0509656A1 Compositions of phytosterols and phytosterolins as immunmodulators
10/21/1992EP0509469A1 Synthetic compounds suitable for the therapy of infections caused by rhinoviruses
10/21/1992EP0509401A1 Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/21/1992EP0509398A1 Quinoxalines, process for their preparation and their use
10/21/1992EP0509019A1 Treatment of human retroviral infections with 2',3'-dideoxyinosine
10/21/1992EP0508999A1 Pharmaceutically active normonyl compounds
10/21/1992CN1065490A Dna sequences which code for virulence characteristics of streptococcus suis and polypeptides and antibody derived therefrom
10/20/1992WO1992018618A1 Modified plant viruses as vectors
10/20/1992US5157128 Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates
10/20/1992US5157116 Antidiabetic agents
10/20/1992US5157114 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
10/20/1992US5157041 Viricides
10/20/1992US5157035 Anti-virally active pyridazinamines
10/20/1992US5156958 Gene encoding a 30 kilodalton outer membrane protein of bordetella pertussis and method of recombinant production of said protein
10/20/1992US5156949 Immunoassays for antibody to human immunodeficiency virus using recombinant antigens
10/20/1992US5156669 Fungicides and plant growth regulators
10/20/1992US5156601 Blend of polyurethane and decyclized poly(N-vinyl lactam)
10/20/1992CA2066394A1 Synthetic compounds suitable for the therapy of infections caused by rhinoviruses
10/20/1992CA2066059A1 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
10/20/1992CA1309097C 2-oxo-1-[[(substituted sulfonyl) amino]- carbonyl]azetidines
10/20/1992CA1309045C Fungal antibiotics bu-3608, bu-3608b and bu-3608c
10/19/1992WO1992018522A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
10/19/1992CA2106386A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
10/19/1992CA2066138A1 Semi-synthetic immunosuppressive macrolides
10/17/1992CA2066132A1 2-phenanthridonyl carbapenems
10/17/1992CA2065883A1 2-phenanthridonyl carbapenems having cationizeable substituents
10/16/1992WO1992018148A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992WO1992018146A1 Novel biologically active peptide compositions and uses therefor
10/16/1992WO1992018143A1 Pharmaceutical compositions against gastric disorders
10/16/1992WO1992018100A1 Antibacterial mild liquid skin cleanser
10/16/1992CA2108467A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof
10/16/1992CA2107001A1 Antibacterial mild liquid surfactant skin cleanser
10/16/1992CA2083594A1 Biologically active peptide compositions and uses therefor
10/16/1992CA2065985A1 Quinoxalines, processes for their preparation, and their use
10/15/1992WO1992017587A1 Bordetella bronchiseptica outer membrane antigen
10/15/1992WO1992017495A1 Antibiotic a 40926 ester derivatives
10/15/1992WO1992017493A2 Peptides and mixtures thereof for detecting antibodies to hepatitis c virus (hcv)
10/15/1992WO1992017490A1 Phosphorus containing compounds as inhibitors of retroviruses
10/15/1992WO1992017479A1 Antibiotic carbapenem derivatives
10/15/1992WO1992017211A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences
10/15/1992WO1992017198A1 Dna and amino acid sequence specific for natural killer cells
10/15/1992WO1992017197A1 Novel peptide compositions and uses therefor
10/15/1992WO1992017186A1 Compounds that prevent endotoxin shock and method of using the compounds
10/15/1992WO1992017169A1 Use of deprenyl to maintain, prevent loss, or recover nerve cell function
10/15/1992WO1992011367A3 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/15/1992CA2107789A1 Retrovirus inhibition with antisense nucleic acids complementary to packaging sequences
10/14/1992WO1992018130A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection
10/14/1992EP0508901A2 Alpha-methylene-4-[(phenoxy)methyl)]5-thiazolacetic acid derivatives, process for their preparation, intermediates in this process, their use as fungicides and compositions containing them
10/14/1992EP0508809A1 Proteinaceous lipid-containing particles
10/14/1992EP0508795A1 8a-aza-8a-homoerythromycin cyclic iminoethers
10/14/1992EP0508783A1 Attenuated poliovirus and vaccines thereof
10/14/1992EP0508726A1 Novel process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
10/14/1992EP0508725A1 Novel process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
10/14/1992EP0508724A1 Radiopharmaceutical bacteriostats
10/14/1992EP0508699A1 9-Deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and 8a-positions
10/14/1992EP0508682A1 Antibiotic carbapenem derivatives
10/14/1992EP0508375A2 Novel cephalosporin compounds and processes for preparation thereof
1 ... 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 ... 1798